86 episodes

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

The Hematologist The Hematologist

    • Science

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

    Year's Best: The BELLINI Study, With Drs. Irene Ghobrial and Shaji Kumar

    Year's Best: The BELLINI Study, With Drs. Irene Ghobrial and Shaji Kumar

    In this podcast, Contributing Editor Dr. Irene Ghobrial has a conversation with Dr. Shaji Kumar. They discuss Dr. Ghobrial’s Year’s Best article from the January/February 2021 issue of The Hematologist, titled, "The BELLINI Study and the Dawn of Precision Medicine in Multiple Myeloma." They discuss a randomized, double-blinded, phase III trial testing the combination of venetoclax or placebo with bortezomib and dexamethasone in relapsed or refractory multiple myeloma. You can access her Year’s Best article online at https://ashpublications.org/thehematologist/article/474709/The-BELLINI-Study-and-the-Dawn-of-Precision.
    Conflicts of Interest: Dr. Kumar has received research funding for clinical trials to the institution from Abbvie, Amgen, BMS, Carsgen, Janssen, KITE, Merck, Medimmune, Novartis, Roche-Genentech, Takeda, and Tenebio, and has consulted or participated in advisory boards (with no personal payments) for Abbvie, Amgen, BMS, Janssen, Roche-Genentech, Takeda, and (with personal payment) Oncopeptides, Beigene. Dr. Ghobrial has consulted for GSK (and Advisory Board participation), Sanofi, Janssen, Takeda, Karyopharm, AbbVie, GNS (Ad. Board participation), Cellectar, Medscape, Genentech, Adaptive, BMS, Aptitude (Ad. Board participation), and Curio Science.
    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    • 14 min
    2020 ASH Annual Meeting: A Guide for Trainees, With Drs. Ajay Major and Lachelle Weeks

    2020 ASH Annual Meeting: A Guide for Trainees, With Drs. Ajay Major and Lachelle Weeks

    In this installment of the 2020 ASH Annual Meeting podcast series, Dr. Ajay Major and Dr. Lachelle Dawn Weeks help members of the trainee community navigate the upcoming 62nd ASH Annual Meeting. They provide important information about events and sessions of interest to the trainee community as well as features of the virtual platform that will help trainees stay connected in this new all-virtual environment. To access these resources and find additional information about what to expect, visit www.hematology.org/annual-meeting.
    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    • 9 min
    2020 ASH Annual Meeting: Disparities in Science, With Drs. Laura Michaelis & Chancellor Donald

    2020 ASH Annual Meeting: Disparities in Science, With Drs. Laura Michaelis & Chancellor Donald

    In this installment of the 2020 ASH Annual Meeting podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Chancellor Donald. They discuss disparities in science, outcomes, and access to care, as well as planned sessions at this year’s ASH Annual Meeting that will address these topics. To access meeting resources and find additional information about what to expect, visit www.hematology.org/annual-meeting.
    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    • 18 min
    Is Dose-adjusted EPOCH-R Enough for Burkitt Lymphoma? With Drs. Brad Kahl and Mark Roschewski

    Is Dose-adjusted EPOCH-R Enough for Burkitt Lymphoma? With Drs. Brad Kahl and Mark Roschewski

    In this podcast, Contributing Editor Dr. Brad Kahl has a conversation with Dr. Mark Roschewski. They discuss Dr. Kahl's Diffusion article from the November/December 2020 issue of The Hematologist, titled, "Is Dose-adjusted EPOCH-R Enough in Burkitt Lymphoma?" They discuss a study that evaluates the efficacy of the dose-adjusted EPOCH-R regimen in adult patients with Burkitt lymphoma. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/472152/Is-Dose-adjusted-EPOCH-R-Enough-in-Burkitt.
    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    • 13 min
    Get Involved With ASH Advocacy, With Drs. Chancellor Donald, Alan Rosmarin, & Laura Michaelis

    Get Involved With ASH Advocacy, With Drs. Chancellor Donald, Alan Rosmarin, & Laura Michaelis

    In this installment of The Hematologist podcast and the COVID-19 podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Chair of the ASH Committee on Practice Dr. Chancellor Donald and Chair of the ASH Committee on Government Relations Dr. Alan Rosmarin about ASH advocacy initiatives, how advocacy has changed as a result of the COVID-19 pandemic, and how interested members can get involved in Society advocacy efforts on behalf of the hematology community. Learn more by visiting www.hematology.org/advocacy. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.
    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    • 20 min
    COVID-19 Update 15: The Latest ASH Resources, With Drs. Stephanie Lee and Laura Michaelis

    COVID-19 Update 15: The Latest ASH Resources, With Drs. Stephanie Lee and Laura Michaelis

    In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with 2020 ASH President Dr. Stephanie Lee. They discuss the latest ASH COVID-19 resources and updates to existing ones, and how Dr. Lee has been dealing with the pandemic since we last heard from her on the very first episode in this series back in March. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.
    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    • 14 min

Top Podcasts In Science

Listeners Also Subscribed To